- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Isotope dilution.
Displaying page 1 of 1.
EudraCT Number: 2012-000808-16 | Sponsor Protocol Number: C11palmitatmetformin | Start Date*: 2013-03-27 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Effects of metformin on hepatic free fatty acid metabolism in type 2 diabetes asssessed by positron emission tomography | |||||||||||||
Medical condition: Type 2 diabetes and dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000667-74 | Sponsor Protocol Number: CV006 | Start Date*: 2021-11-30 | |||||||||||
Sponsor Name:Medisch Centrum Leeuwarden BV | |||||||||||||
Full Title: The effect of bile acid binding with colesevelam on postprandial glucose concentrations in patients after RYGB and cholecystectomy : a meal test study | |||||||||||||
Medical condition: Post Bariatric Hypoglycemia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001579-35 | Sponsor Protocol Number: KBP5074-2-001 | Start Date*: 2019-08-07 | ||||||||||||||||
Sponsor Name:KBP BioSciences Co., Ltd. | ||||||||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Pharmacokinetics of KBP-5074 in Patients with Moderate-to-Severe Chronic Kidney Disea... | ||||||||||||||||||
Medical condition: Moderate to Severe Chronic Kidney Disease and uncontrolled hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001516-30 | Sponsor Protocol Number: GDX-44-007 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:GUERBET | ||||||||||||||||||
Full Title: Pharmacokinetics, safety and efficacy of a new gadolinium-based contrast agent, gadopiclenol, in pediatric patients from 2 to 17 years of ageundergoing contrast-enhanced MRI. | ||||||||||||||||||
Medical condition: Pediatric subjects from 2 to 17 years old scheduled to undergo routine gadolinium contrast enhanced Magnetic Resonance Imaging of Central Nervous System | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: SK (Ongoing) PL (Completed) BG (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
